Approval · Notice of Compliance 22356 · 2019
NETSPOT: Notice of Compliance 22356
Issued July 3, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22356
- Date
- July 3, 2019
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NETSPOT | 02490005 | Marketed |
Medicinal ingredients
- OXODOTREOTIDE 40 MCG per VIAL